Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06700841 in Active Systemic Lupus Erythematosus
CTR20192662Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brepocitinib in systemic lupus erythematosus (SLE), sponsored by Pfizer. Started Mar 2020; status: completed.
02
Drugs
brepocitinib
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20192662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192662.